You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Chat on-demand with a health outcomes consultant

Explore the cost of the Ellipta portfolio and contact us to find out how this could impact your local prescribing.
 

COPD medicines evidence packs

Relvar▼ Ellipta (fluticasone furoate/vilanterol inhalation powder) COPD medicines evidence pack

The Relvar Ellipta Medicines evidence pack in COPD provides information to support payers and HCPs in making a Relvar Ellipta formulary application.

You can access a printer- friendly version of the pack by clicking on the image.

Incruse▼ Ellipta (umeclidinium bromide inhalation powder) COPD medicines evidence pack

The Incruse Ellipta Medicines evidence pack in COPD provides information to support payers and HCPs in making an Incruse Ellipta formulary application.

You can access a printer- friendly version of the pack by clicking on the image.

Anoro▼ Ellipta (umeclidinium/vilanterol inhalation powder) COPD medicines evidence pack

The Anoro Ellipta Medicines evidence pack in COPD provides information to support payers and HCPs in making an Anoro Ellipta formulary application.

You can access a printer- friendly version of the pack by clicking on the image.

 

Asthma medicines evidence pack

Relvar▼ Ellipta (fluticasone furoate/vilanterol inhalation powder) asthma medicines evidence pack

The Relvar Ellipta Medicines evidence pack in asthma provides information to support payers and HCPs in making a Relvar Ellipta formulary application.

You can access a printer- friendly version of the pack by clicking on the image.

 

ANORO ELLIPTA and RELVAR ELLIPTA were developed in collaboration with

Innoviva logo

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

Anoro, Incruse, Relvar and Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies 

N.C. Last updated December 2016. UK/RESP/0486/15(3)